Glaxosmithkline PLC, 10% Owner at Spero Therapeutics, Inc. (SPRO), bought 757,563 shares at $14.00 ($6.0M) on 2017-11-06, disclosed to the SEC on 2017-11-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 328,992 | $0 | 0.0% |
| 2 | $14.00 | 428,571 | $6.0M | 100.0% |
| Total | $7.92 avg | 757,563 | $6.0M | 100% |
| Filing → |
| DBTX | BUY | 2021-02-19 | $2.7M | — | Filing → |
| BCYC | SELL | 2020-09-18 | $151K | — | Filing → |
| GNCA | BUY | 2020-07-30 | $2.8M | — | Filing → |